Literature DB >> 25678194

Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?

Jose-Alberto Palma1, Juan Carlos Gomez-Esteban, Lucy Norcliffe-Kaufmann, Jose Martinez, Beatriz Tijero, Koldo Berganzo, Horacio Kaufmann.   

Abstract

Orthostatic hypotension (OH) is frequent in patients with Parkinson's disease (PD) and can occur with or without symptoms. Pharmacological treatments are effective, but often exacerbate supine hypertension. Guidelines exist for the diagnosis, but not for the treatment of OH. We examined the relationship between blood pressure (BP) and symptoms in a cohort of PD patients with the goal of identifying a hemodynamic target to guide treatment. We measured BP supine and upright (tilt or active standing) and identified the presence or absence of symptomatic OH by using a validated patient-reported outcome questionnaire in 210 patients with PD. We evaluated the usefulness of the 20/10 and 30/15 mmHg diagnostic criteria (systolic/diastolic) to identify symptomatic OH. Fifty percent of the PD patient cohort met criteria for the 20/10 fall and 30% for the 30/15 BP fall. Among the patients who met either OH criteria, the percentage of those with symptoms was small (33% of those with 20/10 and 44% of those with 30/15 mmHg; 16% and 13%, respectively, overall). Symptomatic OH was associated with an upright mean BP below 75 mmHg. A mean standing BP <75 mmHg had a sensitivity of 97% and a specificity of 98% for detecting symptomatic OH. Although the prevalence of OH in PD is high, not all patients have symptoms of organ hypoperfusion. A mean standing BP below 75 mmHg appears to be a useful benchmark when deciding whether the benefits of initiating pharmacological treatment of OH outweigh the risks of exacerbating supine hypertension.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  autonomic failure; consensus criteria; dysautonomia; mean blood pressure; standing blood pressure; supine hypertension

Mesh:

Substances:

Year:  2015        PMID: 25678194      PMCID: PMC4397106          DOI: 10.1002/mds.26079

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  37 in total

1.  Effects of moderate exercise training on plasma volume, baroreceptor sensitivity and orthostatic tolerance in healthy subjects.

Authors:  B L Mtinangi; R Hainsworth
Journal:  Exp Physiol       Date:  1999-01       Impact factor: 2.969

2.  Myoclonus or tremor in orthostatism: an under-recognized cause of unsteadiness in Parkinson's disease.

Authors:  Smaranda Leu-Semenescu; Emmanuel Roze; Marie Vidailhet; André-Pierre Legrand; Jean-Marc Trocello; Valérie Cochen; Sophie Sangla; Emmanuelle Apartis
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

3.  Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment.

Authors:  Jean-Pierre Wolf; Malika Bouhaddi; Francis Louisy; Andrei Mikehiev; Laurent Mourot; Sylvie Cappelle; Fabrice Vuillier; Pierre Andre; Lucien Rumbach; Jacques Regnard
Journal:  Clin Sci (Lond)       Date:  2006-03       Impact factor: 6.124

4.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

5.  Factors maintaining cerebral circulation during gravitational stress.

Authors:  J P HENRY; O H GAUER; S S KETY; K KRAMER
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

Review 6.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy.

Authors:  H Kaufmann
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

7.  Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

8.  Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.

Authors:  P A Low; J L Gilden; R Freeman; K N Sheng; M A McElligott
Journal:  JAMA       Date:  1997-04-02       Impact factor: 56.272

9.  Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy.

Authors:  M Bouhaddi; F Vuillier; J O Fortrat; S Cappelle; M T Henriet; L Rumbach; J Regnard
Journal:  Auton Neurosci       Date:  2004-11-30       Impact factor: 3.145

10.  Statistics review 13: receiver operating characteristic curves.

Authors:  Viv Bewick; Liz Cheek; Jonathan Ball
Journal:  Crit Care       Date:  2004-11-04       Impact factor: 9.097

View more
  49 in total

Review 1.  Orthostatic hypotension: managing a difficult problem.

Authors:  Pearl K Jones; Brett H Shaw; Satish R Raj
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-01

2.  An orthostatic hypotension mimic: The inebriation-like syndrome in Parkinson disease.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Mov Disord       Date:  2016-02-16       Impact factor: 10.338

3.  Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord Clin Pract       Date:  2017-03-16

4.  Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.

Authors:  Lucy Norcliffe-Kaufmann; Horacio Kaufmann; Jose-Alberto Palma; Cyndya A Shibao; Italo Biaggioni; Amanda C Peltier; Wolfgang Singer; Phillip A Low; David S Goldstein; Christopher H Gibbons; Roy Freeman; David Robertson
Journal:  Ann Neurol       Date:  2018-03-10       Impact factor: 10.422

Review 5.  Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.

Authors:  Jacquie Baker; Kurt Kimpinski
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

6.  Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.

Authors:  Juan Francisco Idiaquez; Juan Idiaquez; Juan Carlos Casar; Italo Biaggioni
Journal:  Am J Hypertens       Date:  2021-03-11       Impact factor: 2.689

7.  Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Semin Neurol       Date:  2020-09-09       Impact factor: 3.420

8.  Impact of orthostatic hypotension on wheelchair use in patients with Parkinson's disease.

Authors:  Tomohiko Nakamura; Masashi Suzuki; Masamichi Ueda; Yumiko Harada; Masaaki Hirayama; Masahisa Katsuno
Journal:  J Neural Transm (Vienna)       Date:  2019-12-23       Impact factor: 3.575

Review 9.  [Parkinson's disease in the elderly].

Authors:  Rüdiger Lange; Frank Erbguth
Journal:  Z Gerontol Geriatr       Date:  2017-07-19       Impact factor: 1.281

Review 10.  Pathophysiology and Treatment of Orthostatic Hypotension in Parkinsonian Disorders.

Authors:  Dong In Sinn; Christopher H Gibbons
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.